Generation Bio Co. — Investor Relations & Filings
Generation Bio Co. is a biotechnology company developing therapeutics for T cell-driven autoimmune diseases. The company's platform utilizes proprietary cell-targeted lipid nanoparticles (ctLNPs) to selectively deliver small interfering RNA (siRNA) to T cells. This approach is designed to potently silence specific genes and modulate the function of autoreactive T cells responsible for tissue and organ damage. The technology aims to provide redosable treatments with genetic precision and tunable pharmacology, while sparing the broader immune system from off-target effects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| SCHEDULE 13G/A Filing | 2026-02-11 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-10 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English | |
| 4 - Generation Bio Co. (0001733294) (Issuer) | 2026-02-09 | English |
Browse filings by year
8 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Breath of Life International Ltd.
A prominent producer of medical cannabis products, engaged …
|
BOLP | CA | Manufacturing |
|
BriaCell Therapeutics Corp.
Developing targeted cellular immunotherapies using whole-ce…
|
BCTX | CA | Manufacturing |
|
BridgeBio Oncology Therapeutics, Inc.
Clinical-stage biopharma developing inhibitors for genetica…
|
BBOT | US | Manufacturing |
|
BridgeBio Pharma, Inc.
Develops transformative medicines for genetic diseases and …
|
BBIO | US | Manufacturing |
|
Brightgene Bio-Medical Technology Co., Ltd.
Research-driven developer of complex APIs, high-end generic…
|
688166 | CN | Manufacturing |
|
BRIGHT MINDS BIOSCIENCES INC.
Develops selective serotonin agonists for neurological and …
|
DRUG | US | Manufacturing |
|
BrightPath Biotherapeutics Co., Ltd.
A clinical-stage biopharma company developing cancer immuno…
|
4594 | JP | Manufacturing |
|
Brii Biosciences Limited
Developing first-in-class therapies targeting infectious an…
|
2137 | KY | Manufacturing |
|
BRISTOL MYERS SQUIBB CO
A global biopharmaceutical company that discovers, develops…
|
BMY | US | Manufacturing |
|
BROOKS LABORATORIES LIMITED
Pharmaceutical manufacturer specializing in CRAMS and diver…
|
BROOKS | IN | Manufacturing |
Generation Bio Co. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34688/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34688 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34688 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34688 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34688}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Generation Bio Co. (id: 34688)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.